Clinical trial
Will Decreased Noradrenergic Activity Normalize Information Processing in…
NCT00206986 · Birte Glenthoj, Other · Completed
Key facts
| NCT number | NCT00206986 |
|---|---|
| Title | Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia? |
| Official title | Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia? |
| Lead sponsor | Birte Glenthoj, Other |
| Collaborators | University of Copenhagen Lundbeck Foundation Glostrup University Hospital, Copenhagen |
| Status | Completed |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | clonidine |
| Enrollment | 40 |
| Start date | May 1, 2005 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Sep 21, 2005 |
| Last update posted | Dec 20, 2013 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: